NASDAQ:CBDC - Apotheca Biosciences Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Apotheca Biosciences Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0001 -0.02 (-99.50 %) (As of 02/26/2020 04:00 PM ET) Add Compare Today's Range$0.00Now: $0.00▼$0.0050-Day Range$0.00MA: $0.01▼$0.0252-Week Range$0.00Now: $0.00▼$0.31Volume5,500 shsAverage Volume10,768 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Apotheca Biosciences, Inc. develops cutting-edge medical products, nutraceuticals, formulation, and delivery technologies for the healthcare and consumer care industry. The company is based in the United States. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CBDC Previous Symbol CUSIPN/A CIKN/A WebN/A Phone727-228-3994Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive CBDC News and Ratings via Email Sign-up to receive the latest news and ratings for CBDC and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:CBDC Rates by TradingView Apotheca Biosciences (NASDAQ:CBDC) Frequently Asked Questions What is Apotheca Biosciences' stock symbol? Apotheca Biosciences trades on the NASDAQ under the ticker symbol "CBDC." Has Apotheca Biosciences been receiving favorable news coverage? News articles about CBDC stock have been trending somewhat positive on Wednesday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Apotheca Biosciences earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Apotheca Biosciences. Who are some of Apotheca Biosciences' key competitors? Some companies that are related to Apotheca Biosciences include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Almirall (LBTSF), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE), Canada House Wellness Group (CHV), Cannabics Pharmaceuticals (CNBX), CannaRoyalty (ORHOF), Cardiome Pharma (COM), China Longyi Group Int'l (CGYG) and Creative Medical Technology (CELZ). What other stocks do shareholders of Apotheca Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apotheca Biosciences investors own include Cross Timbers Royalty Trust (CRT), Aphria (APHA), Prospect Capital (PSEC), ARBOR RLTY TR I/SH (ABR), BP Prudhoe Bay Royalty Trust (BPT), Canopy Growth (CGC), NGL Energy Partners (NGL), InfraCap MLP ETF (AMZA), Chemesis International (CADMF) and Hemp (HEMP). Who are Apotheca Biosciences' key executives? Apotheca Biosciences' management team includes the folowing people: Dr. P. C. Sundareswaran, Chairman, CEO & CFOMs. Deirdre Fernandes, COO & DirectorMr. John Verghese, CTO & Director (Age 58)Mr. Craig Huffman, Legal CouncilKarin Rohret, Sec. How do I buy shares of Apotheca Biosciences? Shares of CBDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Apotheca Biosciences' stock price today? One share of CBDC stock can currently be purchased for approximately $0.00. How can I contact Apotheca Biosciences? The company can be reached via phone at 727-228-3994. MarketBeat Community Rating for Apotheca Biosciences (NASDAQ CBDC)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 24 (Thanks for Voting!)Underperform Votes: 35 (Thanks for Voting!)Total Votes: 59MarketBeat's community ratings are surveys of what our community members think about Apotheca Biosciences and other stocks. Vote "Outperform" if you believe CBDC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBDC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/26/2020 by MarketBeat.com StaffFeatured Article: Why do earnings reports matter?
